Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Embryonic Stem Cell Research Receives Widespread Support From Americans

Recent poll finds 72% of adults surveyed believe research has merit


News provided by

Harris Interactive

Oct 07, 2010, 11:08 ET

Share this article

Share toX

Share this article

Share toX

NORWALK, Conn., Oct. 7 /PRNewswire/ -- A large majority of Americans across various demographic groups agree that scientists should be able to use stem cells for biomedical research, according to a recent Harris Interactive/HealthDay poll.  

(Logo:  http://photos.prnewswire.com/prnh/20100518/NY06801LOGO )

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100518/NY06801LOGO )

Almost three quarters of adults surveyed are in favor of using embryonic stem cells left over from in vitro fertilization procedures to search for potential prevention or treatment of diseases such as Parkinson's disease, Alzheimer's, diabetes and other conditions.  These poll results remain consistent with a similar survey released in 2005.

This poll took place at a critical juncture in legal arguments surrounding stem cell research in the United States.  Recently, U.S. District Court Judge Royce Lamberth ruled that federal funding of embryonic stem cell research violated a 1996 law prohibiting the use of taxpayer dollars for such work. The Obama administration appealed that decision. Soon after, an appeals court issued a temporary suspension of the ban until it could hear full arguments over the next few weeks.

"There is now overwhelming public support for using embryonic stem cells in biomedical research," said Humphrey Taylor, chairman of the Harris Poll, a service of Harris Interactive. "Even among Catholics and born-again Christians, relatively few people believe that stem cell research should be forbidden because it is unethical or immoral."

Paul Sanberg, distinguished professor of neurosurgery and director of the University of South Florida Center of Excellence for Aging and Brain Repair in Tampa, said, "This [poll] shows that the public still believes that stem cells could lead to important therapeutics."

The poll was conducted online between Sept. 28-30 and included 2,113 adults ages 18 and over. Among its other findings:

  • Seventy-three percent (versus 72 percent in 2005) believe that stem cell research should be allowed "as long as the parents of the embryo give their permission, and the embryo would otherwise be destroyed."
  • Fifty-eight percent of Republicans think stem cell research is acceptable (versus 24 percent opposed), as do 69 percent of Catholics and 58 percent of born-again Christians. Sixteen percent of Catholics and 22 percent of born-again Christians oppose it.
  • Two-thirds of the respondents agreed that, "If most scientists believe that stem cell research will greatly increase our ability to prevent or treat serious diseases we should trust them and let them do it."


 

The complete finding of this joint Harris Interactive/HealthDay poll is available online here. HealthDay's news report is available here. Full data on the poll and its methodology are available at Harris Interactive.

TABLE 1

SHOULD EMBRYONIC STEM CELLS BE
USED IN MEDICAL RESEARCH

"Stem cells come from embryos, left over from in vitro fertilization, which are not used and normally destroyed.  Many medical researchers want to use them to develop treatments or to prevent diseases such as diabetes, Alzheimer's or Parkinson's disease.  On balance, do you think this research should be allowed or not be allowed?"


Base:  All Adults

 

 

All Adults

Party

Religion

 

Rep.

Dem.

Ind.

Catholic

Protestant

Other

Christian/

Other Religion

Born-Again Christian

 

%

%

%

%

%

%

%

%

 

Should be allowed

72

58

82

73

69

74

66

58

 

Should not be allowed

12

24

4

10

16

11

15

22

 

Not Sure

17

18

13

18

16

14

19

20

 

Percentages may not add up exactly to 100% due to rounding.


 
 
                 
 

TABLE 2

SHOULD STEM CELL RESEARCH BE ALLOWED – TRENDED

"Stem cells come from embryos, left over from in vitro fertilization, which are not used and normally destroyed.  Many medical researchers want to use them to develop treatments or to prevent diseases such as diabetes, Alzheimer's or Parkinson's disease.  On balance, do you think this research should be allowed or not be allowed?"


Base:  All Adults

 

 

All Adults

 

2001

2004

2005

Sept. 2010

 

%

%

%

%

 

Should be allowed

61

73

74

72

 

Should not be allowed

21

11

14

12

 

Not sure/refused

18

16

12

17

 

Percentages may not add up exactly to 100% due to rounding.


 
 
         
 

TABLE 3

AGREE/DISAGREE WITH VARIOUS STATEMENTS

"Please indicate whether you tend to agree or disagree with the following statements."


Base: All Adults

 

 

Tend to Agree

Tend to Disagree

Not Sure/Refused

 

Using cells from human
embryos for research comes
too close to allowing scientists
to play God.


 

2001

%

40

53

7

 

2004

%

19

57

24

 

2005

%

23

58

20

 

NOW

%

20

60

20

 

Allowing any medical research
using stem cells from human
embryos should be forbidden
because it is unethical and immoral.


 

2001

%

32

60

8

 

2004

%

15

63

22

 

2005

%

17

66

17

 

NOW

%

17

62

21

 

If the federal government does not
fund stem cell research from human
embryos, the United States will fall
behind other countries in terms of
leadership in the development of new
drugs and preventing diseases.


 

2005

%

54

25

21

 

NOW

%

51

23

26

 

I don't believe that we should put the
interests of medical science ahead of
the preservation of human life, which
includes human embryos.

2005

%

27

48

24

 

NOW

%

28

47

25

 

Note:  Percentages may not add up exactly to 100% due to rounding.


 
 
           
 

TABLE 3 cont.

AGREE/DISAGREE WITH VARIOUS STATEMENTS

"Please indicate whether you tend to agree or disagree with the following statements."


                  Base: All Adults

 

 

Tend to Agree

Tend to

Disagree

Not Sure/

Refused

 

As long as the parents of the embryo
give their permission, and the embryo
would otherwise be destroyed, stem cell
research should be allowed.

2001

%

72

21

7

 

2004

%

72

13

15

 

2005

%

72

15

13

 

NOW

%

73

13

14

 

If most scientists believe that stem
cell research will greatly increase our
ability to prevent or treat serious
diseases we should trust them and
let them do it.

2001

%

63

29

7

 

2004

%

67

16

18

 

2005

%

65

17

18

 

NOW

%

66

15

20

 

Percentages may not add up exactly to 100% due to rounding.


 
 
           
 

TABLE 4

STEM CELL RESEARCH SHOULD BE FORBIDDEN BECAUSE IT IS
UNETHICAL AND IMMORAL

"Please indicate whether you tend to agree or disagree
with the following statements."


Base:  All Adults

 

 

Total

Party Identification

Religious Affiliation

 

Rep.

Dem.

Ind.

Catholic

Protestant

Other

Christian/

Other Religion

Born-Again Christian

 

%

%

%

%

%

%

%

%

 

Tend to agree

17

29

11

15

20

14

23

34

 

Tend to disagree

62

51

69

66

61

66

51

41

 

Not sure

21

21

19

19

19

20

27

26

 

Percentages may not add up exactly to 100% due to rounding.


 
 
                 
 

Methodology

This survey was conducted online within the United States September 28 to 30, 2010 among 2,113 adults (aged 18 and over). Figures for age, sex, race/ethnicity, education, region and household income were weighted where necessary to bring them into line with their actual proportions in the population. Propensity score weighting was also used to adjust for respondents' propensity to be online.

All sample surveys and polls, whether or not they use probability sampling, are subject to multiple sources of error which are most often not possible to quantify or estimate, including sampling error, coverage error, error associated with nonresponse, error associated with question wording and response options, and post-survey weighting and adjustments. Therefore, Harris Interactive avoids the words "margin of error" as they are misleading. All that can be calculated are different possible sampling errors with different probabilities for pure, unweighted, random samples with 100% response rates. These are only theoretical because no published polls come close to this ideal. 

Respondents for this survey were selected from among those who have agreed to participate in Harris Interactive surveys. The data have been weighted to reflect the composition of the adult population. Because the sample is based on those who agreed to participate in the Harris Interactive panel, no estimates of theoretical sampling error can be calculated.

Full data available at www.harrisinteractive.com

The results of this Harris Poll may not be used in advertising, marketing or promotion without the prior written permission of Harris Interactive.

These statements conform to the principles of disclosure of the National Council on Public Polls. 

About HealthDay

HealthDay, a division of Scout News LLC, is a leading producer and syndicator of evidence-based health news for consumers and physicians and is the largest syndicator of that news to Internet sites. Its consumer health news service (http://www.healthday.com/) appears on more than 5,000 Web sites such as Yahoo!, MSN, iVillage, US News & World Report, hundreds of hospital and hospital group Web sites, as well as print publication Web sites across the country. HealthDay also produces Physician's Briefing (http://www.physiciansbriefing.com/), a news service for physicians, nurses and other medical professionals updated twice daily providing 15 articles a day across 27 medical specialties. HealthDay also provides custom content for major health portals. The newest addition to the HealthDay portfolio is HealthDay TV -- a 90-second news broadcast of essential health information that appears on several major media Web sites, U.S. government Web sites and other health information sites.

About Harris Interactive

Harris Interactive is one of the world's leading custom market research firms, leveraging research, technology, and business acumen to transform relevant insight into actionable foresight. Known widely for the Harris Poll and for pioneering innovative research methodologies, Harris offers expertise in a wide range of industries, including health care, technology, public affairs, energy, telecommunications, financial services, insurance, media, retail, restaurant, and consumer package goods. Serving clients in more than 215 countries and territories through its North American, European, and Asian offices and a network of independent market research firms, Harris specializes in delivering research solutions that help clients stay ahead of what's next. For more information, please visit www.harrisinteractive.com.  

Press Contact:

 

Harris Interactive

 

212-539-9600

 

[email protected]

 
 
 

SOURCE Harris Interactive

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.